ArticleEye (London, England)2025

Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6.

Swati Chandak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.